| |
| |
|
| Insider
Information: |
Buell Jennifer |
| Relationship: |
|
| City: |
Lexington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
359,256 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$56,365 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
359,256 |
|
|
| Total
Value |
$56,365 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Antigenics Inc |
AGEN |
COO and President |
2021-06-30 |
127,091 |
|
0 |
Premium* |
|
|
Mink Therapeutics, Inc. |
INKT |
|
2023-10-11 |
232,165 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
12 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| INKT |
Mink Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-10-11 |
4 |
D |
$0.00 |
$0 |
D/D |
(695,750) |
232,165 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-10-03 |
4 |
D |
$0.94 |
$61,419 |
D/D |
(65,000) |
927,915 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-10-02 |
4 |
D |
$1.04 |
$61,155 |
D/D |
(58,550) |
992,915 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Chief Executive Officer |
• • – |
2023-09-29 |
4 |
D |
$1.15 |
$28,845 |
D/D |
(25,000) |
1,051,465 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2023-09-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
695,750 |
1,076,465 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
Chief Executive Officer |
• – – |
2023-01-09 |
4 |
A |
$2.32 |
$399,017 |
D/D |
171,990 |
380,715 |
0 |
- |
|
| INKT |
Mink Therapeutics, Inc. |
See RemarksOfficer |
• • – |
2021-10-13 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
208,725 |
|
- |
|
| AGEN |
Antigenics Inc |
COO and President |
• – – |
2021-06-30 |
4 |
A |
$5.49 |
$58,178 |
D/D |
10,597 |
127,091 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Communications Officer |
• – – |
2017-12-12 |
4 |
S |
$3.46 |
$12,152 |
D/D |
(3,511) |
35,656 |
0 |
- |
|
| AGEN |
Antigenics Inc |
Chief Communications Officer |
• – – |
2017-10-09 |
4 |
A |
$3.59 |
$37,447 |
D/D |
10,431 |
39,167 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Research & External Affairs |
• – – |
2017-09-03 |
4 |
A |
$3.72 |
$16,275 |
D/D |
4,375 |
28,736 |
0 |
- |
|
| AGEN |
Antigenics Inc |
VP Research & External Affairs |
• – – |
2017-06-29 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,361 |
|
- |
|
12 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
